Loading…
Lobbying Spend
—
Filings
34
Firms Hired
2
Active Period
2014–2020
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Elijah E. Cummings Lower Drug Costs Now Act
2020 · first_quarter · Firm: IPOLICY SOLUTIONS
HR4400 Advancing Education on Biosimilars Act of 2019 S. 1895, Lower Health Care Costs Act HR3 Elijah E. Cummings Lower Drug Costs Now Act H.R.4455 - BIOSIM Act Biosimilar Policy
Client expense: — · Firm income: $19,500
Matched citations: HR3
Advancing Education on Biosimilars Act of 2019
2020 · first_quarter · Firm: IPOLICY SOLUTIONS
HR4400 Advancing Education on Biosimilars Act of 2019 S. 1895, Lower Health Care Costs Act HR3 Elijah E. Cummings Lower Drug Costs Now Act H.R.4455 - BIOSIM Act Biosimilar Policy
Client expense: — · Firm income: $19,500
Matched citations: HR4400
HR4400 Advancing Education on Biosimilars Act of 2019 S. 1895, Lower Health Care Costs Act HR3 Elijah E. Cummings Lower Drug Costs Now Act H.R.4455 - BIOSIM Act Biosimilar Policy
Client expense: — · Firm income: $19,500
Matched citations: H.R.4455
HR4400 Advancing Education on Biosimilars Act of 2019 S. 1895, Lower Health Care Costs Act HR3 Elijah E. Cummings Lower Drug Costs Now Act H.R.4455 - BIOSIM Act Biosimilar Policy
Client expense: — · Firm income: $19,500
Matched citations: S. 1895
Elijah E. Cummings Lower Drug Costs Now Act
2019 · fourth_quarter · Firm: IPOLICY SOLUTIONS
HR4400 Advancing Education on Biosimilars Act of 2019 S. 1895, Lower Health Care Costs Act HR3 Elijah E. Cummings Lower Drug Costs Now Act H.R.4455 - BIOSIM Act
Client expense: — · Firm income: $27,000
Matched citations: HR3
Advancing Education on Biosimilars Act of 2019
2019 · fourth_quarter · Firm: IPOLICY SOLUTIONS
HR4400 Advancing Education on Biosimilars Act of 2019 S. 1895, Lower Health Care Costs Act HR3 Elijah E. Cummings Lower Drug Costs Now Act H.R.4455 - BIOSIM Act
Client expense: — · Firm income: $27,000
Matched citations: HR4400
HR4400 Advancing Education on Biosimilars Act of 2019 S. 1895, Lower Health Care Costs Act HR3 Elijah E. Cummings Lower Drug Costs Now Act H.R.4455 - BIOSIM Act
Client expense: — · Firm income: $27,000
Matched citations: H.R.4455
HR4400 Advancing Education on Biosimilars Act of 2019 S. 1895, Lower Health Care Costs Act HR3 Elijah E. Cummings Lower Drug Costs Now Act H.R.4455 - BIOSIM Act
Client expense: — · Firm income: $27,000
Matched citations: S. 1895
Drug pricing Insurance coverage policy Access to biosimilars S. 1895, Lower Health Care Costs Act
Client expense: — · Firm income: $27,000
Matched citations: S. 1895
Prescription Drug Price Transparency Act
2018 · fourth_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Drug Pricing Biosimilars Patient Right to Know Drug Pricing Act, S.2554 Know the Lowest Price Act of 2018, S. 2553 Know the Cost Act of 2018, H.R. 6733 Medicare Part B coverage policy Health Reimbursement Arrangements
Client expense: — · Firm income: $30,000
Matched citations: HR 1316
Medical Product Communications Act of 2017
2018 · fourth_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Drug Pricing Biosimilars Patient Right to Know Drug Pricing Act, S.2554 Know the Lowest Price Act of 2018, S. 2553 Know the Cost Act of 2018, H.R. 6733 Medicare Part B coverage policy Health Reimbursement Arrangements
Client expense: — · Firm income: $30,000
Matched citations: HR 1703
Know the Cost Act of 2018
2018 · fourth_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Drug Pricing Biosimilars Patient Right to Know Drug Pricing Act, S.2554 Know the Lowest Price Act of 2018, S. 2553 Know the Cost Act of 2018, H.R. 6733 Medicare Part B coverage policy Health Reimbursement Arrangements
Client expense: — · Firm income: $30,000
Matched citations: H.R. 6733
Know the Lowest Price Act of 2018
2018 · fourth_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Drug Pricing Biosimilars Patient Right to Know Drug Pricing Act, S.2554 Know the Lowest Price Act of 2018, S. 2553 Know the Cost Act of 2018, H.R. 6733 Medicare Part B coverage policy Health Reimbursement Arrangements
Client expense: — · Firm income: $30,000
Matched citations: S. 2553
Patient Right to Know Drug Prices Act
2018 · fourth_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Drug Pricing Biosimilars Patient Right to Know Drug Pricing Act, S.2554 Know the Lowest Price Act of 2018, S. 2553 Know the Cost Act of 2018, H.R. 6733 Medicare Part B coverage policy Health Reimbursement Arrangements
Client expense: — · Firm income: $30,000
Matched citations: S.2554
Prescription Drug Price Transparency Act
2018 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Drug Pricing Biosimilars Patient Right to Know Drug Pricing Act, S.2554 Know the Lowest Price Act of 2018, S. 2553 Know the Cost Act of 2018, H.R. 6733
Client expense: — · Firm income: $30,000
Matched citations: HR 1316
Medical Product Communications Act of 2017
2018 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Drug Pricing Biosimilars Patient Right to Know Drug Pricing Act, S.2554 Know the Lowest Price Act of 2018, S. 2553 Know the Cost Act of 2018, H.R. 6733
Client expense: — · Firm income: $30,000
Matched citations: HR 1703
Know the Cost Act of 2018
2018 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Drug Pricing Biosimilars Patient Right to Know Drug Pricing Act, S.2554 Know the Lowest Price Act of 2018, S. 2553 Know the Cost Act of 2018, H.R. 6733
Client expense: — · Firm income: $30,000
Matched citations: H.R. 6733
Know the Lowest Price Act of 2018
2018 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Drug Pricing Biosimilars Patient Right to Know Drug Pricing Act, S.2554 Know the Lowest Price Act of 2018, S. 2553 Know the Cost Act of 2018, H.R. 6733
Client expense: — · Firm income: $30,000
Matched citations: S. 2553
Patient Right to Know Drug Prices Act
2018 · third_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Drug Pricing Biosimilars Patient Right to Know Drug Pricing Act, S.2554 Know the Lowest Price Act of 2018, S. 2553 Know the Cost Act of 2018, H.R. 6733
Client expense: — · Firm income: $30,000
Matched citations: S.2554
Prescription Drug Price Transparency Act
2018 · second_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Trickett Wendier, Frank Morigeiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018, HR 5247, S 204
Client expense: — · Firm income: $30,000
Matched citations: HR 1316
Medical Product Communications Act of 2017
2018 · second_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Trickett Wendier, Frank Morigeiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018, HR 5247, S 204
Client expense: — · Firm income: $30,000
Matched citations: HR 1703
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018
2018 · second_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Trickett Wendier, Frank Morigeiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018, HR 5247, S 204
Client expense: — · Firm income: $30,000
Matched citations: HR 5247
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
2018 · second_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Trickett Wendier, Frank Morigeiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018, HR 5247, S 204
Client expense: — · Firm income: $30,000
Matched citations: S 204
Prescription Drug Price Transparency Act
2018 · first_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Trickett Wendier, Frank Morigeiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018, HR 5247, S 204
Client expense: — · Firm income: $30,000
Matched citations: HR 1316
Medical Product Communications Act of 2017
2018 · first_quarter · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Trickett Wendier, Frank Morigeiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018, HR 5247, S 204
Client expense: — · Firm income: $30,000
Matched citations: HR 1703
Source: Senate LDA